Skip to main content

Innovative medicines for europe

Objective

The discovery and development of new drugs is very costly and attrition rates are high. Initiatives to reduce the rate of attrition during later phases are clearly desirable and if successfully implemented will reduce development costs. The InnoMed proposal addresses the complex issues associated with the future of biomédical research in the EU, and addresses ways of achieving accelerated development of, safe and more effective medicines, aiming to revitalize the European biopharmaceutical research environment. InnoMed's wide consortium base, being led by the European Federation of Pharmaceutical Industry and Associations (EFPIA), guarantee's a commitment from all the stakeholders needed to change the process of drug development in Europe. The course for addressing the necessary changes is to first develop a Strategic Research Agenda (SRA) that will encompass the whole path from discovery of a new drug target to the validation and approval stages of a new drug compound. This will be agreed by all the relevant stakeholders via meetings and workshops. Four key bottlenecks in the drug development process will be addressed: Safety Efficacy Knowledge Management Training and Education This comprehensive strategy with a detailed roadmap will lead to the deployment of a European Technology Platform (ETP). This European Technology Platform will deliver added value to the drug discovery and development process and to individual stakeholders. To ensure the relevance of the ETP InnoMed will validate it using two research proposals, AddNeuroMed, which will develop and validate novel surrogate markers based upon in vitro and in vivo models in animals and humans, using Alzheimer's disease as a testing platform. PredTox will deliver new biomarkers of toxicity and a greater understanding of mechanisms of toxicity. Both of these projects will demonstrate the viability and necessity of the ETP.

Call for proposal

FP6-2004-LIFESCIHEALTH-5
See other projects for this call

Coordinator

EUROPEAN FEDERATION OF PHARMACEUTICAL INDUSTRIES AND ASSOCIATIONS
Address
Rue Du Trône 108
Brussels
Belgium

See on map

Participants (41)

F. HOFFMANN-LA ROCHE LTD
Switzerland
Address
Grenzacherstrasse 124
Basel

See on map

BOEHRINGER INGELHEIM GMBH
Germany
Address
Binger Strasse 173
Ingelheim

See on map

EUROPEAN FEDERATION OF BIOTECHNOLOGY
Belgium
Address
Université De Liège, Place Du 20 Août, 7. C/o: Professor Bernard Rentier, Vice-rector
Liège

See on map

INSTITUT DE RECHERCHES INTERNATIONALES SERVIER
France
Address
6 Place Des Pleiades
Courbevoie

See on map

ELI LILLY AND COMPANY
United States
Address
Lilly Corporate Center
Indianapolis, Indiana

See on map

MERCK KGAA
Germany
Address
Frankfurter Strasse 250
Darmstadt

See on map

NOVO NORDISK A/S
Denmark
Address
Novo Allé
Bagsvaerd

See on map

PHARMIDEX PHARMACEUTICAL SERVICES LIMITED
United Kingdom
Address
72 New Bond Street
London

See on map

JULIUS-MAXIMILLIAMS-UNIVERSITAET WUERZBURG
Germany
Address
Sanderring 2
Würzburg

See on map

CAPSANT NEUROTECHNOLOGIES LTD
United Kingdom
Address
2 Venture Road, Chilworth Science Park
Southampton

See on map

UNIVERSITY OF KUOPIO
Finland
Address
Savilahdentie 9
1627 Kuopio

See on map

UNIVERSITA DEGLI STUDI DI PERUGIA
Italy
Address
Piazza Dell'universita 1
Perugia

See on map

ARISTOTLE UNIVERSITY OF THESSALONIKI
Greece
Address
Administration Building - University Campus
Thessaloniki

See on map

ROSKILDE UNIVERSITETSCENTER
Denmark
Address
Universitetsvej 1
260 Roskilde

See on map

ASTRAZENECA AB
Sweden
Address

Södertälje

See on map

KUNGLIGA TEKNISKA HOEGSKOLAN
Sweden
Address
Valhallv 79
Stockholm

See on map

KAROLINSKA INSTITUTET
Sweden
Address
Nobels Väg 5
Stockhom

See on map

NOVARTIS PHARMA AG
Switzerland
Address
Lichtstrasse 35
Basel

See on map

N.V. ORGANON
Netherlands
Address
Molenstraat 110
Oss

See on map

GENEDATA AG
Switzerland
Address
Maulbeerstrasse, 46
Basel

See on map

KING'S COLLEGE, LONDON
United Kingdom
Address
Strand
London

See on map

ISTITUTO DI RICERCHE BIOMEDICHE "A. MARXER" RBM SPA
Italy
Address
Via Ribes, 1
Colleretto Giacosa

See on map

CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
France
Address
2 Rue Viguerie Hôtel-dieu St Jacques Tsa 80035
Toulouse

See on map

GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LTD
United Kingdom
Address
980 Great West Road
Brentford, Middlesex

See on map

UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
Ireland
Address
Belfield
Dublin 4

See on map

PROTEOME SCIENCES PLC
United Kingdom
Address
Coveham House, Downside Bridge Road
Cobham

See on map

HACETTEPE UNIVERSITESI
Türkiye
Address
Sihhiye
Ankara

See on map

UNIVERSITY COLLEGE LONDON
United Kingdom
Address
Gower St
London

See on map

UNIVERSITY OF SOUTHAMPTON
United Kingdom
Address
University Road, Highfield
Southampton

See on map

HUNTER FLEMING LIMITED
United Kingdom
Address
Regus House, 1 Friary, Temple Quay
Bristol

See on map

SANOFI-AVENTIS DEUTSCHLAND GMBH
Germany
Address
Industriepark Hoechst, Bldg. G879
Frankfurt

See on map

ARTTIC IN BRUSSELS SPRL
Belgium
Address
7 Rue De Livourne Bte 4
Brussels

See on map

JANSSEN PHARMACEUTICA N.V
Belgium
Address
Turnhoutseweg 30
Beerse

See on map

BIOWISDOM LIMITED
United Kingdom
Address
Harston Mill, Harston
Cambridge

See on map

CEREBRICON LTD.
Finland
Address
Microkatu 1
1188 Kuopio

See on map

EUROPEAN FEDERATION FOR PHARMACEUTICAL SCIENCES
Sweden
Address
Wallingatan 26a
1136 Stockholm

See on map

DEPARTMENT OF OLD AGE PSYCHIATRY & PSYCHOTIC DISORDERS, MEDICAL UNIVERSITY OF LODZ
Poland
Address
Czechoslowacka 8/10
Lodz

See on map

CIPHERGEN BIOSYSTEMS, INC.
United States
Address
6611 Dumbarton Circle
Fremont, California

See on map

NYCOMED GMBH
Germany
Address
Byk-gulden-str. 2
Konstanz

See on map

AVENTIS PHARMA RECHERCHE-DÉVELOPPEMENT
France
Address
13 Quai Jules Guesde
Vitry Sur Seine

See on map

BAYER PHARMA AG
Germany
Address
Muellerstrasse 178
Berlin

See on map